Sanofi launches its obesity drug in U.K. market

Article Abstract:

The new anti-obesity drug Accomplia by Sanofi-Aventis S.A. of France has been launched in the United Kingdom. The drug was approved by the European Union and will be launched in other European countries and possibly the United States by the end of the year. One month's supply costs 55.20 Pounds ($100.60).

United Kingdom, Product development, France, European Union, Licensing, certification and accreditation, SNY, Sanofi-Aventis S.A., Accomplia (Medication)

---

Drug makers win big patent victory

Article Abstract:

Merck KGaA of Germany, in a precedent setting patent case against Integra Life Sciences Corp. of the United States has won. The pharmaceutical industry is permitted free rein in early-stage research and found not liable for patent infringement litigation according to the United States Supreme Court.

United States, Company legal issue, Cases, Germany, Merck KGAA, United States. Supreme Court, Patent infringement, Integra LifeSciences Corp.

---

Similar abstracts:

• Abstracts: Brazil challenges patented drugs. Drug pact will give boost to trade talks. Trade officials near AIDS drug pact
• Abstracts: Cash pinch hits China's markets after tightening. China to drain cash from banking system
• Abstracts: Stay tuned ... please! Big top television. From destination to journey
• Abstracts: Special electric winches of Canadian dredger. Marco opens tuna ship service shop
• Abstracts: In Europe, can one size fit all? Slowdown in Germany and Italy may delay ECB's rate increase. European spending plan leaves Central Bank leery

This website is not affiliated with document authors or copyright owners. This page is provided for informational purposes only. Unintentional errors are possible.